COMAC MEDICAL is taking its identity and direction forward with the launch of the 2026 Next Chapter event.

Comac Medical is a trusted Pan-European, full-service Contract Research Organization (CRO) with over 27 years of experience. We offer comprehensive in-house clinical trial solutions for different stages of clinical trials from Phase I to Phase IV, and clinical investigation services for medical devices and food supplements. Our mission is to deliver smart solutions with unwavering quality, efficiency, and timeliness, accelerating medical innovation for all our partners, patients, and society. 🌏 Operating in 24 countries across Europe and Eurasia, we conduct over 1500 clinical research studies, accessing treatment-naive patient populations with support from 350+ full-time employees. Specializing in therapeutic areas such as oncology, dermatology, cardiology, gastroenterology, neurology, and more, we provide tailored expertise to meet specific client needs. Comac Medical’s Early Phase Clinical Research Unit (CRU) combines 18 years of expertise in Phase I, Bioavailability, and Bioequivalence (BA/BE) studies with state-of-the-art facilities in Sofia, Bulgaria—the largest and finest Phase I Unit in Southeastern Europe. Join forces with us to gain access to top clinical research scientists, dedicated medical professionals and clinical trial experts. Comac Medical is your trusted partner for clinical research excellence! 🚀